Hunan Kelun Pharmaceutical Co., Ltd.

This early-stage study tests a new drug called KLA578-1 in 48 healthy volunteers aged 18 to 45. The main goal is to check if the drug is safe and how the body processes it. Participants will receive either a single dose or multiple doses, and researchers will monitor for side eff…

This early-stage study tests whether a new drug called KLA318-2 is safe and how the body processes it. About 48 healthy adults aged 18-45 will receive a single injection. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.

This early-stage study tests a single dose of an experimental drug called KL0011034 in 76 healthy Chinese volunteers aged 18-45. The main goal is to check for side effects and how the drug moves through the body. Participants are randomly assigned to receive the drug, a placebo, …

This early-stage study tests whether a single dose of KLA478 is safe and how the body processes it. About 40 healthy adults aged 18-45 will receive the drug and be monitored for side effects and drug levels in the blood. No treatment benefit is expected; the goal is to gather saf…